Jinyu Bio-Technology Hits Day High with Strong 3.58% Intraday Surge

Jinyu Bio-Technology Co., Ltd. has experienced a notable increase of 3.58% on June 29, 2026, reaching an intraday high of CNY 12.05. This performance stands out against the backdrop of the China Shanghai Composite, which rose by 1.16% on the same day. Over the past year, Jinyu has generated a remarkable return of 113.02%, significantly outperforming the market's 22.49% return. Despite this positive short-term performance, the company faces challenges in terms of long-term growth, with net sales declining at an annual rate of -1.07% over the last five years. Additionally, Jinyu has reported negative results for the last four consecutive quarters, indicating ongoing financial difficulties. The company's return on capital employed (ROCE) is low at 6.64%, reflecting limited profitability per unit of capital. With a market capitalization of CNY 13,276 million, Jinyu operates within the pharmaceuticals and biotechnology sector. The stock's price-to-earnings ratio stands at 129.00, and it currently offers a dividend yield of 0.25%.